1. Introduction
At the end of 2019, a novel strain of coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), was identified in China. Compared to previous outbreaks, COVID-19 was deemed extremely dangerous due to its high rate of contagion, severe symptoms and elevated mortality rates [
1,
2]. According to the World Health Organization (WHO), more than 259 million confirmed cases of COVID-19 and more than 5 million deaths have been registered worldwide, to this date [
3]. Although the pandemic has a global dimension, the virus impact on each human being is different, and the severity of the disease (mild, moderate, severe or fatal) varies depending on the age and pre-existent pathologies (e.g., cardiovascular, respiratory, cerebrovascular and immunodeficiency) of each individual [
4]. The most common symptoms are fever, cough, fatigue, sputum production, headache, hemoptysis, diarrhea, dyspnea and lymphopenia. On average, these symptoms start manifesting after five days of incubation [
2,
4]. The airborne transmission of the SARS-CoV-2 virus between people occurs through contact (direct or indirect) with air containing infected aerosols or respiratory droplets [
5]. Worldwide, several preventive measures have been proposed, including social distancing, disinfection of objects, self-hygiene (e.g., hand washing) and the use of personnel protective equipment (e.g., face masks and respirators) [
6]. In several countries, the use of protective masks is mandatory within closed public spaces. However, most of this equipment has a passive action against COVID-19 [
5]. There have been reports stating that the virus can remain infectious in standard surgical masks for up to seven days [
7]. The permanence of the active virus in masks thus reinforces the need for more innovative and effective protective options to help contain its spreading [
8].
Essential oils (EOs) are a complex mixture of volatile and aromatic chemical compounds (e.g., terpenes, phenols, alcohols, aldehydes, ethers and ketones) extracted from different parts of plants (e.g., buds, flowers, stems, leaves, seeds, twigs, roots, fruits, bark and wood flowers, seeds, leaves, fruits and roots) [
9,
10,
11,
12]. These have the function of defending the host from microbial invasion, manifesting antibacterial, antifungal and insecticide activities, aside from antiviral [
13,
14,
15]. Furthermore, EOs have anti-inflammatory, immunomodulatory and bronchodilatory properties [
16]. They are widely available in nature, have low water solubility, strong lipophilicity and low toxicity [
9,
10,
14]. Their composition, and consequently inherent properties, are dependent on the harvest date [
17], cultivation conditions [
18] and geographical area [
19], plant variety [
20], plant or part of the plant age [
21], extraction system [
22], among others. EOs have shown important effects against several pathogenic viruses by penetrating the viral membranes and triggering their rupture [
16]. Therefore, the use of EOs may be an advantageous approach when dealing with the SARS-CoV-2 [
16,
23,
24]. Garlic oil (GLO), for example, can inhibit the activity of the angiotensin-2 converting enzyme protein, leading SARS-CoV-2 to lose its host receptor and attack its main protease, the PDB6LU7 protein, hindering virus maturation, proliferation and colonization [
25]. It is also known that inhaling certain EOs together with steam has a positive impact on bronchiolitis, colds, rhinosinusitis, allergies, flu and asthma [
23]. Several EOs have been studied and applied in biomedicine [
9,
26], including lemongrass (LGO), Niaouli (NO) and eucalyptus (ELO) [
11]. LGO has citral (3,7-dimethyl-2,6-octadienal) as the most abundant and biologically active compound within its composition [
27]. This oil has antioxidant characteristics, anti-inflammatory and analgesic properties, and good activity against a plethora of fungal, bacterial and viral species [
27,
28,
29]. Furthermore, this oil is frequently used to treat fever, flu, colds and pneumonia [
29,
30]. NO is extracted from
Melaleuca quinquenervia and is rich in 1,8-cineole (eucalyptol). NO is described as having a strong antimicrobial action and to intervene in the treatment of respiratory infections and by attenuating coughs and colds [
31,
32]. Like NO, ELO has good antimicrobial properties, specifically antiviral [
33], and is frequently used in traditional folk medicine to treat respiratory tract disorders and infections [
34,
35]. It is also composed essentially of 1,8-cineole, limonene, α-pinene, γ-terpinene, and α-terpineol [
33]. To this date, neither of these EOs has been examined for its potential against the SARS-CoV-2 virus, either alone or as part of human personnel protective equipment.
Despite the antiviral potential of EOs, their sensitivity to external factors (temperature, light and oxygen) and their volatile nature tend to limit their application [
10]. Nevertheless, recent studies have described the protective effect of polymeric fibers on the EOs, as a way to ensure their stability and to preserve their chemical composition [
11,
14]. Electrospinning is one of the most common techniques employed in the production of fine polymeric fibers (ranging the nanometer scale), with great flexibility, excellent mechanical properties and a continuous three-dimensional, intricated network [
36,
37,
38,
39]. This technique is simple, inexpensive, effective, and versatile. More importantly, films resulting from electrospinning are porous and possess a highly interconnected architecture that allows easy incorporation of biomolecules of interest [
38], such as EOs [
40].
In this study, we propose the production of polycaprolactone (PCL) fibrous mats loaded with selected antiviral EOs, via electrospinning, for prospective applications in individual protective masks (as intermediate layers). PCL is a synthetic biodegradable polymer produced by the ring-opening polymerization of ε-caprolactone monomer using a wide range of catalysts [
36]. Due to its biocompatibility, excellent mechanical strength, miscibility with other polymer solutions, slow degradation rate and non-toxicity, PCL is widely used in biomedicine and tissue engineering systems [
11,
36]. Indeed, there are several medical devices (i.e., ‘Monocryl’ sutures, ‘Capronor’ birth control device, etc.) made of this material that have been approved by the Food and Drug Administration (FDA) for human uses [
41]. PCL networks have also shown abilities to serve as delivery platforms for a variety of biomolecules, namely EOs [
11,
40]. Therefore, the main objective of the present study is to explore the antiviral potential of selected EOs, while integrated into PCL electrospun mats, against the
Escherichia coli MS2 virus (a potential surrogate of SARS-CoV-2). This bacteriophage is a non-pathogenic virus, consisting of an icosahedral capsid and used to study human pathogenic viruses such as Influenza A and B, as well as SARS-CoV [
42,
43]. Such parallelism is possible due to the similarity in resistance to antimicrobial agents and the ease of preparation and testing between them [
42]. Although there are some studies that explore the potential of polymeric PCL networks loaded with EOs for other purposes [
38,
44], to the authors’ knowledge, none has proposed such an endeavor yet.
2. Experimental Section
2.1. Materials
Twenty EOs were purchased from
Folha d’Água (Santo Tirso, Portugal).
Table 1 provides detailed information about each one. Their selection was made based on the EOs inherent antibacterial activity, reported previously by our team [
11].
E. coli bacteriophage MS2 (ATCC 15597B1) and respective
E. coli host (ATCC 15597) were supplied from American Type Culture Collection (ATCC). Both bacteriophage and host were incubated in ATCC
® Medium 271 (M271). A water-based solution composed of 10 g/L tryptone, 1 g/L yeast extract and 8 g/L sodium chloride was autoclaved at 121 °C, and then aseptically combined with an aqueous solution containing 1 g/L of glucose, 0.294 g/L of calcium chloride and 0.01 g/L of thiamine. Petri dishes containing M271 agar, at 5%
w/
v (top layer) and 15%
w/
v (bottom layer) concentration, were used as solid media. PCL (Mn 80,000), chloroform (CHL) and dimethyl formamide (DMF) were purchased from Sigma-Aldrich and used without further purification.
2.2. Minimum Bactericidal Concentrations (MBC) and Virucidal Concentrations (VC)
MBCs were determined using the broth microdilution method described by Wiegand et al. [
45], which adapts the standard published by the Clinical and Laboratory Standards Institute (CLSI) and the European Committee on Antimicrobial Susceptibility Testing (EUCAST) [
46].
EOs were diluted in M271 at 50–1.25%
v/
v, which corresponded to an average maximum concentration of 481.80 ± 71.10 mg/mL and an average minimum concentration of 12.05 ± 1.78 mg/mL; maximum and minimum concentrations for each oil were dependent on their inherent density (
Table 1). Working solutions prepared at 50, 40, 30, 20, 10, 5, 2.5, 1.25%
v/
v of EOs in M271 (defined based on the averaged MICs obtained for the 20 selected oils against
E. coli bacterium [
11]) were added (50 μL) to each column of the 96-well plates. Then, to each of these wells, 50 μL of the
E. coli (host) suspension prepared at 1 × 10
7 colony forming units (CFUs)/mL in M271 were added.
E. coli suspension without EOs and culture media were used as controls. Absorbance readings at a wavelength of 600 nm (EZ READ 2000 Microplate Reader, Biochrom Ltd., Cambridge, UK) were performed before and after plate incubation at 37 °C and 120 rpm for 24 h, for minimum inhibitory concentration (MIC) determinations. The bacterium was then cultured on M271 agar plates (preparation of aliquots of 10 μL of each bacteria suspension diluted from 10
1 to 10
5 in phosphate-buffered saline solution, PBS) at MIC and at a concentration in its vicinity (higher and lower) and the number of CFUs/mL were counted. Absence of viable colonies on agar after 24 h of culture at 37 °C established MBC rates.
The VC of each EO against the bacteriophage MS2, prepared at 1 × 107 plaque-forming units (PFUs)/mL in M271, was determined using the same concentrations and volumes selected for MIC testing. After 24 h incubation at 37 °C and 120 rpm, all suspensions contacting with the bacteriophage were cultured on bacterium-seeded two-layer agar plates (diluted from 101 to 105 in M271). The agar plates were prepared by inoculating bacterium in the top layer (liquid state) of agar. The host is required for the virucidal effect to be detectable and PFUs/mL to be counted. Absence of bacteriophage plates on agar after 24 h of culture at 37 °C established VC rates. The three most effective EOs against the bacteriophage MS2 (factoring the effect on the host) were highlighted from the group and used in the subsequent experiments. Those same three EOs were also examined for their composition via solid-phase micro-extraction followed by gas chromatography-mass spectrometry (SPME-GC-MS), by exposing the SPME fiber (100 μm polydimethylsiloxane) to the vapor phase above the EOs sample (at 1 mg/mL) for a period of 4 h at 35 °C (temperature of exhaled air).
2.3. Electrospun Fibrous Mats Production and EOs Loading
PCL was solubilized at 14 wt.% in CHF/DMF (9/1 v/v) under constant stirring of 150 rpm and room temperature (RT), for 24 h (control). Viscosity was assessed using a viscometer Brookfield DV-II+Pro (from Hadamar-Steinbach, Germany, with spindle 21, processed at 15 rpm at 25.3 °C during 10 min, with 30 s time points), while conductivity was determined using a Thermo Scientific Benchtop Meter (Orion Versa Star Pro, Waltham, MA, USA). A fixed voltage of 23 kV was applied to the steel capillary needle with an inner diameter of 21 Gauge (G). The solution feeding rate was set at 0.7 mL/h, with an aluminum collecting sheet being positioned at 26 cm from the needle tip for fiber recovery. Temperature and relative humidity (RH) were controlled and maintained at 20–22 °C and 60–65%, respectively.
EOs were incorporated within the PCL mats via two ways: (1) blending prior to fiber extrusion (labeled as PCLbEOs) and (2) physical adsorption after obtaining the fibers (labeled as PCLaEOs). In strategy (1), the EOs at 10% VC were blended for 24 h with a freshly prepared PCL solution (150 rpm and RT). To prevent interferences with the EOs stability, solutions were maintained protected from light until extrusion. These were characterized (viscosity and conductivity) and processed via electrospinning following the same parameters established for PCL, the only exception being the voltage which was fixed at 26 kV. In approach (2), samples of 11 mm of diameter were cut using a metal puncher from PCL mats and immersed in EO’s alcoholic solutions prepared at 10% v/v VC for 24 h at 150 rpm (orbital shaking), protected from light. In the end, mats were collected, and unbound molecules were eliminated with a 5 min ethanol washing at 150 rpm (orbital shaking). Ethanol traces on the mats were eliminated after drying for 24 h in a desiccator with controlled RH of ≈41%.
2.4. Morphological Examinations
Micrographs of the PCL, PCLaEOs and PCLbEOs fibrous structures were acquired with an accelerating voltage of 10 kV using a field emission gun scanning electron microscope (FEG-SEM, NOVA 200 Nano SEM, FEI Company, Hillsboro, Oregon, USA). Mats were initially coated with a thin film (10 nm) of Au-Pd (80–20 wt%) using a 208HR high-resolution sputter coater (Cressington Company, Watford, UK) coupled to an MTM-20 Cressington High Resolution Thickness Controller. Average fiber diameters were determined by conducting 100 fiber measurements on three micrographs of each type, simulating the diameter distribution with a log-normal function [
47]. Images at a magnitude of 10,000× were used and processed using the ImageJ software (version 1.51j8, National Institute of Health, Bethesda, MD, USA). The number of layers and porosity level of the mats were analyzed using the Python 3.8 software (Python, Amsterdam, The Netherlands).
2.5. Detection of EOs via Fourier-Transform Infrared Spectroscopy with Attenuated Total Reflectance (ATR-FTIR)
An IRAffinity-1S, SHIMADZU spectrophotometer (Kyoto, Japan), with an ATR accessory (diamond crystal), was used to investigate the PCL, PCLbEOs and PCLaEOs mats’ chemical groups. For each mat, a total of 200 scans were performed at a spectral resolution of 2 cm−1, over the wavenumber range of 700–4000 cm−1.
2.6. EOs Loading and Release Kinetics
EO loading was determined via two ways, using UV-visible spectroscopy: (1) indirectly, in adsorbed surfaces (PCLaEOs), by measuring the absorbance of the loading (t = 0 h and t = 24 h) and washing solutions, using a UV–1800 UV-vis spectrophotometer (Shimadzu, Kyoto, Japan) and subtracting that amount to t = 0 h, this way allowing to determine the mass of EOs integrated into each mat; and (2) directly, analyzing the oil-blended mats (PCLbEOs) with a UV-2600 UV-vis spectrophotometer (Shimadzu, Kyoto, Japan) and an integrating sphere (ISR-2600Plus) with a film holder for transmittance analysis (film rectangles with 6 × 2 cm2 sliced from the mats centered regions). In each strategy, calibration curves were made for the tested EOs to identify relevant peaks.
EOs release kinetics from the engineered mats was mapped over a period of 4 h (recommended maximum time for mask use). Samples of 11 mm diameter (including control without oils) were immersed in 1 mL of distilled water (dH2O) and incubated at 150 rpm and RT for 30 min, 1, 2 and 4 h. At the end of each period, the solution was collected and absorbance measurements (200–500 nm) were conducted using the UV-1800. The % of EOs released from the mats was determined based on absorbance differences between time 0 h and the defined testing periods. Any alterations in the absorbance of the control samples (PCL) were considered and subtracted from the final absorbance for each tested sample.
2.7. Quantification of EOs Release by GC-MS
The EOs (LGO, NO and ELO) release study was carried out via headspace (HS) by exposing the SPME fiber (100 μm polydimethylsiloxane) to the vapor phase above the sample matrix, followed by GC-MS evaluation. The SPME fiber was inserted in the middle of the vial containing the sample and exposed for 4 h at 35 °C (temperature of exhaled air) [
48].
The samples were quantified by GC-MS using manual injection of the SPME fiber. Gas chromatographic analyses were carried out using a Varian 4000 system (Walnut Creek, CA, USA) with a split/splitless injector coupled to a mass spectrometer. Injections were operated at 250 °C in the split mode 1:10 using an Rxi-5Sil MS (Restek, Bellefonte, PA, USA) column (30 m × 0.25 mm, and 0.25 μm film thickness), with a column-head pressure of 7.3 psi using helium as carrier gas. The oven temperature started at 45 °C and was held for 5 min; the temperature increased until 250 °C at a rate of 7 °C/min. A full scan mode (50–750 m/z) was applied for the identification of the target compound. The mass spectrometer (MS) was operated in electron ionization (EI) mode at 70 eV with total ion chromatogram (TIC) detection mode for quantitative determination and S/N ratio of 5. Calibration curves of the oils were accomplished using the same testing conditions of the samples (temperature and time). Each time point was evaluated separately, and all the measurements were performed in triplicate. The amount of oil was determined by the integration of the peaks from chromatograms and quantified against the calibration curves.
2.8. Qualitative Assessment of EOs Release: Sensory Evaluation
Odor intensity assessments were conducted on PCL, PCLaEOs and PCLbEOS by a group of 45 people, a number considered acceptable for such a trial [
49]. In this sensory evaluation, the general impression of a group of untrained volunteer participants, such as students and employees of the University of Minho, with no experience as panelists in sensory evaluation, was collected [
50]. Before starting the sensory assessment, each participant received a questionnaire (
Figure S1) to fill out during the sensory assessment and its purpose was explained. Each participant placed the samples 1 to 2 cm distant from the nose and breathed in the odor for 30 s. Intervals of 30 s were made between samples of sensory evaluation to reduce cross-adaptation and perception influence for decision making [
51]. Descriptive, discriminatory (such as ordering test and pair comparison) and affective analyses were conducted [
49]. For each odor, the subjective intensity perceived by each participant was analyzed. After inhaling each odor, the participants were asked to rank the mats in ascending order of intensity and to indicate the intensity of each mat using a scale from 0 to 5, where 0 = not perceptible, 1 = weakly/not perceptible, 2 = moderately perceptible, 3 = clearly perceptible, 4 = strongly perceptible, and 5 = very strongly perceptible [
52]. Consecutively, a test of comparison by pairs between EOs loading strategies (blended or absorbed) was carried out, with the participants having to select the mat that exuded the greatest odor intensity from each pair. Finally, participants performed an affective analysis by classifying mats according to their unpleasant or pleasant odor quality using a hedonic scale from −4 to 4, where −4 = extremely unpleasant, −3 = moderate unpleasant, −2 = unpleasant, −1 = slightly unpleasant, 0 = not unpleasant but not pleasant, +1 = slightly pleasant, +2 = pleasant, +3 = moderate pleasant, and +4 = extremely pleasant [
51,
53].
2.9. Thermal Stability
Thermal gravimetric analyses (TGA) were conducted by weight loss monitoring with an increase of temperature in the range of 25–500 °C, at a heating rate of 10 °C/min under a dynamic nitrogen atmosphere and flow rate of 200 mL/min (inert environment) on an STA 7200 Hitachi® (Fukuoka, Japan), using aluminum pans. The initial mass of each sample was established at 3.44 ± 0.32 mg. Results were plotted as % of weight loss vs temperature. Differential scanning calorimetry (DSC) evaluations were conducted in a DSC 822 Mettler Toledo (Columbus, OH, USA). Samples of 3.04 ± 0.17 mg were submitted to a temperature range of 0–500 °C heated at a rate of 10 °C/min, under a dynamic nitrogen atmosphere, and flow rate of 200 mL/min (inert environment). DSC curves were plotted as heat flow vs. temperature.
2.10. Mechanical Performance
The tensile strength and elongation at break of the unloaded and EOs-loaded PCL mats were evaluated using a Hounsfield H5KS dynamometer (Artilab, Kerkdriel, The Netherlands) associated with the QMAT Materials Testing & Analysis software, following the standard ASTM D5035. Three rectangular-shaped specimens of 6 cm long and 2 cm width were cut from each film. The average thickness of the samples was determined at 0.09 ± 0.01 mm using a handheld analogical micrometer with a dial indicator from Mitotoyo (ref. 2046F, Senhora da Hora, Portugal) with a resolution of 0.01 mm, 10 mm pressing area and 18 Pa of pressure. The gauge length and grip distance were established at 2 cm. The crosshead speed was 10 mm/min and the selected load cell was 2.5–250 N, used with a load range of 25 N and a pre-load of 0.2 N. Experiments were performed at RT.
2.11. Wettability and Degree of Swelling
Water contact angle measurements were conducted in a Contact Angle OCA 15, Data Physics apparatus (Filderstadt, Germany) connected to a video-based drop shape analyzer OCA15 plus software, following the standard ASTM-D7334–08. Droplets of 10 μL of dH
2O were used to evaluate the mats’ wettability via the sessile drop measurement. Six measurements were performed per type of sample. Angles were recorded immediately after drop contact with the surface. The mats’ degree of swelling (DS) was determined by measuring the weight of the samples before and after immersion in dH
2O for 4 h (recommended maximum time for mask use) at 150 rpm. DS was calculated using the following equation (Equation (1)) and reported in %:
where
mw (mg) is the weight of the wet film,
md (mg) is the weight of the dry film.
2.12. Air and Water-Vapor Permeabilities
The mats’ ability in promoting air exchange was determined according to standard ISO 9237 using an FX 3300 LABOTESTER III, TEXTEST Instrument (Schwerzenbach, Switzerland). An air pressure of 40 Pa (differential pressure defined on EN ISO 14683:2019 as the minimum required for particle filtering of medical face masks) was applied onto six different and equidistant points on three samples of each type, under an area of 5 cm2. Air permeabilities were reported in L/cm2.
On water vapor permeability examination (standard BS 7209:1990), mats were placed on top of cylindrical cups containing 46 mL of dH
2O for 4 h. The evaporation of water through the test sample was determined by weighing the cup before and after the testing period. Examinations were performed at RT of 19–21 °C and 61–64% RH (triplicates). Water vapor permeability standard testing fabric (defined in BS 7209:1990) was used as a control. The water vapor transmission rate (WVTR) and the water vapor permeability index (
I) were determined using Equation (2):
where ∆
W is the difference in the water weight (g) before and after the 4 h test,
A is the inner area of the cup (mm), ∆
t is the exposure time (h), WVPs is the water vapor permeability of the samples and
WVPr is the water vapor permeability of reference (standard testing fabric).
Commercial surgical masks with ≥95% (certified in conformity with EN149:2001+A1:2009, no brand, China) and of ≥98% protection (certified in conformity with EN1483:2019, Pharmia, Portugal) were used for comparison purposes.
2.13. Bacteriophage Permeability
An adaptation of the Kirby-Bauer method was implemented to examine the mats’ permeability or lack of it against the
Escherichia virus MS2. Agar plates seeded with the host bacteria were prepared and left to solidify (see
Section 2.2). After, samples of 1.1 cm in diameter were gently placed on top of the agar and loaded with droplets of 5 µL containing the bacteriophage prepared at 1 × 10
7 PFUs/mL in M271. This volume was defined to mimic high-risk interactions between COVID-19 patients, for instance, in which droplet transmission after coughing or sneezing may occur. Plates were incubated for 4 and 24 h at 37 °C. Images were collected and examined for the presence (permeable) or absence (impermeable) of phage plaques.
2.14. Bacteriophage Contact Inactivation
Bacteriophage solutions were prepared at 1 × 107 PFUs/mL in M271 and inoculated in the form of 50 µL loads (a volume defined to cover the entire surface without leaking to the exterior) on top of unloaded and EOs-loaded PCL mats of 1.1 cm in diameter. Samples were incubated for 4 h at RT (mimicking mask use conditions). In the end, mats were submerged in 5 mL of M271 and vortexed for 3 min for thorough washing of the surfaces and detachment of bacteriophage plaques. Finally, bacteriophage-containing suspensions (diluted from 101 to 105 in M271) were cultured on bacterium-seeded two-layer agar plates and incubated for 24 h at 37 °C. Grown plaques were counted and converted into log reduction (mean ± S.D.). For the purposes of eliminating the effect of the EOs on the host, equal experiments were conducted with E. coli. However, instead of washing and preparing diluted suspensions for plate culturing with M271, PBS was used.